#Truvada

Every-other-month cabotegravir injections may work even better than daily pills for HIV prevention.

Starting today, the CDC recommends that clinicians prescribe pre-exposure prophylaxis to anyone who asks for it.

NoiseFilter’s latest animated HIV series explains U=U, PrEP and PEP—with help from trans activist Milan Nicole Sherry.

Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.

Injections of cabotegravir given once every two months may work even better than daily pills for HIV prevention.

More HIV prevention misinformation is coming from the right.

According to a recent study, transgender women might benefit more than they think from the prevention pill.

Sometimes the older formulation of tenofovir is a better choice for HIV prevention.

Little HIV prevention research has included pregnant women for fear of adverse birth outcomes.

The U.S. government clarified that health insurers must cover PrEP and the associated doctor visits and tests. Here’s why.

Awareness of the HIV prevention pills don’t match their use.

HIV clinics could lose over $100 million each year—notably those serving Black, brown, queer and Southern communities.

Several formulations of generic Truvada are now available at a lower cost.

The HIV prevention bill now heads to the Oregon Senate. Here’s why better PrEP and PEP access could help Latinos and Black Americans.

Study also finds that trans girls are more likely to receive gender-affirming care than trans boys.

An East Harlem HIV prevention campaign focuses on Black and Latino New Yorkers at higher risk.